Cite

HARVARD Citation

    FROMMEYER, G. et al. (2016). Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole‐Heart Model of Short QT Syndrome. Journal of cardiovascular electrophysiology. pp. 1214-1219. [Online]. 
  
Back to record